Novogen's Kelly to Focus on US Units
5th Sep 2005, 13:16 GMT
Novogen said that Graham Kelly resigned from the company's board to focus on the expansion and development of the Australian biopharmaceutical company's US units.
Latest news from Executive Announcements News from myHealthcareNews.com:
- Anika Therapeutics Appoints Constance Garrison as VP of Regulatory and Clinical Affairs
- Accuro Healthcare Solutions Announces New CTO
- Streamline Health named to Forbes Magazine's List of The 200 Best Small Companies for 2006
- Southern Research CEO Jack Secrist Recognized for Contributions in Cancer Drug Research
- Zuckerman named treasurer for CHW
- MQ Assoc Announces Results for Q3 of 2006 and 9 Months Ended 9/30/2006
- KB Home CEO Leaves After Errors Found
- NanoLogix Appoints Global Auto Industry Executive as SVP
- CryoCath named to Deloitte's Technology Fast 500
- Is Your Cat Tight-Lipped When it Comes to His Health? A New Study Finds it's Time to Get Him to Open Wide!